imatinib mesylate has been researched along with Agammaglobulinemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, R; Bansal, D; Jain, R; Malhotra, P; Naseem, S; Sharma, M; Thipparapu, S; Totadri, S; Trehan, A; Varma, N | 1 |
| Alfieri, P; Arcari, A; Ferrari, A; Leonardi, G; Longo, G; Luppi, G; Maffei, R; Marasca, R; Martinelli, S; Piacentini, F; Santachiara, R; Torelli, G; Trabacchi, E; Vallisa, D | 1 |
| Aláez, C; Arranz, E; de la Cámara, R; Fernández-Rañada, JM; Granda, A; Moreno, G; Muñoz, C; Osorio, S; Reino, FG; Salvanés, FR; Steegmann, JL | 1 |
| Azzarà, A; Buda, G; Cannizzo, E; Carulli, G; Cervetti, G; Galimberti, S; Orciuolo, E; Petrini, M | 1 |
2 trial(s) available for imatinib mesylate and Agammaglobulinemia
| Article | Year |
|---|---|
Imatinib-Induced Hypogammaglobulinemia in Children and Adolescents with Chronic Myeloid Leukemia.
Topics: Adolescent; Adult; Agammaglobulinemia; Child; Child, Preschool; Cross-Sectional Studies; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male | 2020 |
Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia.
Topics: Adolescent; Adult; Agammaglobulinemia; Aged; Antineoplastic Agents; Autoimmunity; Benzamides; Drug Resistance; Drug Tolerance; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Immunoglobulins; Immunophenotyping; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Treatment Outcome | 2003 |
2 other study(ies) available for imatinib mesylate and Agammaglobulinemia
| Article | Year |
|---|---|
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.
Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Female; gamma-Globulins; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunoglobulins; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Retrospective Studies | 2008 |
Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemia.
Topics: Adult; Agammaglobulinemia; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines | 2008 |